C207 Data-Driven Decision Making QUM2 Task 2 Decision
Tree Analysis 2025 NEW UPDATE PASSED TASK Western
Governors University
Part A:
Is it best for MPC to develop a new drug line, try to find new uses for the existing drug
line, or continue with the current drug line as is?
Part B:
Choices In In In Profits Other
favorable favorable unfavorable per unit factors
market market market
New drug 69% 4133 units 1355 units .65 Scheduled
likelihood per month per month for FDA
of success approval in
1st quarter
, New use for 61% 5577 units 1911 units .77
current drug likelihood per month per month
of success
Continue 77% 657 units 258 units per .87 Only two
with current likelihood per month month competitors
drug (as is) of success
Part C1:
Part C2:
Tree Analysis 2025 NEW UPDATE PASSED TASK Western
Governors University
Part A:
Is it best for MPC to develop a new drug line, try to find new uses for the existing drug
line, or continue with the current drug line as is?
Part B:
Choices In In In Profits Other
favorable favorable unfavorable per unit factors
market market market
New drug 69% 4133 units 1355 units .65 Scheduled
likelihood per month per month for FDA
of success approval in
1st quarter
, New use for 61% 5577 units 1911 units .77
current drug likelihood per month per month
of success
Continue 77% 657 units 258 units per .87 Only two
with current likelihood per month month competitors
drug (as is) of success
Part C1:
Part C2: